Response of histiocytoses to imatinib mesylate:... [J Clin Oncol. 2010] - PubMed

Save items

loading

Related citations in PubMed

Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-kit, c-abl, and arg proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy. [J Neurooncol. 2006]
Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-kit, c-abl, and arg proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy.
Haberler C, Gelpi E, Marosi C, Rössler K, Birner P, Budka H, Hainfellner JA. J Neurooncol. 2006 Jan; 76(2):105-9.
Imatinib as a treatment option for systemic non-Langerhans cell histiocytoses. [Arch Dermatol. 2007]
Imatinib as a treatment option for systemic non-Langerhans cell histiocytoses.
Utikal J, Ugurel S, Kurzen H, Erben P, Reiter A, Hochhaus A, Nebe T, Hildenbrand R, Haberkorn U, Goerdt S, et al. Arch Dermatol. 2007 Jun; 143(6):736-40.
Response of a KIT-positive extra-abdominal fibromatosis to imatinib mesylate and KIT genetic analysis. [J Natl Cancer Inst. 2006]
Response of a KIT-positive extra-abdominal fibromatosis to imatinib mesylate and KIT genetic analysis.
Gonçalves A, Monges G, Yang Y, Palmerini F, Dubreuil P, Noguchi T, Jacquemier J, Di Stefano D, Delpero JR, Sobol H, et al. J Natl Cancer Inst. 2006 Apr 19; 98(8):562-3.
Review Molecular research directions in the management of gastrointestinal stromal tumors. [Curr Treat Options Oncol. 2005]
Review Molecular research directions in the management of gastrointestinal stromal tumors.
Tarn C, Godwin AK. Curr Treat Options Oncol. 2005 Nov; 6(6):473-86.
Review Role of KIT and platelet-derived growth factor receptors as oncoproteins. [Semin Oncol. 2004]
Review Role of KIT and platelet-derived growth factor receptors as oncoproteins.
Fletcher JA. Semin Oncol. 2004 Apr; 31(2 Suppl 6):4-11.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Response of histiocytoses to imatinib mesylate: fire to ashes.
Response of histiocytoses to imatinib mesylate: fire to ashes.
J Clin Oncol. 2010 Nov 1 ;28(31):e633-6. doi: 10.1200/JCO.2010.29.9073. Epub 2010 Aug 23 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Response of histiocytoses to imatinib mesylate: fire to ashes.

Source

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information